Nomura Holdings Inc Ionis Pharmaceuticals Inc Transaction History

Nomura Holdings Inc

$70.8 Billion
Q4 2024

A detailed history of Nomura Holdings Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nomura Holdings Inc holds 357,255 shares of IONS stock, worth $10.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

357,255

Previous 453,069 21.15%

Holding current value

$10.2 Million

Previous $18.1 Million 31.19%

% of portfolio

0.02%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$33.73 - $40.36 $3.23 Million - $3.87 Million	-95,814 Reduced 21.15%	357,255 $12.5 Million
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $1.93 Million - $2.5 Million	-48,119 Reduced 9.6%	453,069 $18.1 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $1.11 Million - $1.45 Million	30,351 Added 6.45%	501,188 $23.9 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $19.8 Million - $25.2 Million	470,837 New	470,837 $20.4 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $1.3 Million - $1.54 Million	29,878 Added 6.5%	489,189 $24.7 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $921,343 - $1.13 Million	23,931 Added 5.5%	459,311 $20.8 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $1.18 Million - $1.48 Million	34,057 Added 8.49%	435,380 $17.9 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $42,512 - $52,159	1,266 Added 0.32%	401,323 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $450,970 - $565,171	12,149 Added 3.13%	400,057 $15.1 Million
Q3 2022 Nov 15, 2022	BUY	$36.54 - $48.66 $435,958 - $580,562	11,931 Added 3.17%	387,908 $17.1 Million
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $576,392 - $781,611	-18,177 Reduced 4.61%	375,977 $14.3 Million
Q1 2022 May 18, 2022	BUY	$29.88 - $37.04 $647,619 - $802,804	21,674 Added 5.82%	394,154 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $109,303 - $149,806	-4,268 Reduced 1.13%	372,480 $11.3 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $32,869 - $39,739	-980 Reduced 0.26%	376,748 $12.6 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $13 Million - $17.8 Million	377,728 New	377,728 $15 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $200,562 - $300,914	-4,718 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $213,725 - $284,353	4,718 New	4,718 $267,000
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $1.04 Million - $1.58 Million	-24,882 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $1.34 Million - $1.62 Million	24,882 New	24,882 $1.5 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $2.28 Million - $3.16 Million	-36,725 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $319,213 - $489,617	-6,032 Reduced 14.11%	36,725 $2.99 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $141,950 - $194,874	-3,273 Reduced 7.11%	42,757 $2.31 Million
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $418,337 - $523,897	-9,756 Reduced 17.49%	46,030 $2.31 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $177,318 - $221,812	4,375 Added 8.51%	55,786 $2.02 Million
Q1 2018 May 14, 2018	SELL	$44.08 - $55.05 $2.81 Million - $3.51 Million	-63,711 Reduced 55.34%	51,411 $2.27 Million
Q1 2018 May 14, 2018	BUY	$44.08 - $55.05 $2.27 Million - $2.83 Million	51,411 Added 80.69%	115,122 $5.48 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $628,800 - $804,939	-12,501 Reduced 16.4%	63,711 $3.21 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $3.47 Million - $4.54 Million	76,212	76,212 $3.86 Million

Others Institutions Holding IONS

# of Institutions

407

Shares Held

131M

Call Options Held

829K

Put Options Held

789K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.05B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Ionis Pharmaceuticals Inc Transaction History